Sanofi and Transgene announced a biotech partnering agreement for the creation of a new state-of-the-art industrial platform dedicated to the production of immunotherapy products including Transgene’s therapeutic products. Read the full story

Roche. a big biotech company, and BioLamina announced the signing of a research and development biotech partnering to jointly develop new cell culture systems for various applications, including stem cell research Read the full story

Big pharma partnering has often been focussed on the ‘mega deal’ where the value of the deal exceeds $1 billion Read the full story

Smaller, more targeted deals may be the way of the future as big pharma partnering seeks to outsource early stage R&D and risk Read the full story

Ezose Sciences has entered into a biotech partnering deal with Kyowa Hakko Kirin, a big pharma company, to collaborate on glycomics studies using Ezose’s proprietary GlycanMap technology platform Read the full story

Biotechs are starting to turn to other smaller companies as biotech partnering alliances, a recent survey finds Read the full story

Daiichi Sankyo, a big pharma company, and Amplimmune have entered into a broad strategic biotech partnering to develop a new therapeutic protein, AMP-110.   Read the full story

In a M&A deal announcement, Dendreon Corporation  announced the sale of its immunotherapy manufacturing facility  based in Morris Plains, New Jersey, to Novartis Pharmaceuticals Corporation for $43 million in cash

Isis Pharmaceuticals and AstraZeneca announced a strategic biotech partnering alliance for the discovery and development of novel generation antisense therapeutics against five cancer targets.

Read the full story

ImmuNext has entered into a biotech partnering agreement with Janssen Biotech, Inc., focused on the development of novel therapeutics that modulate the immune system for the treatment of cancer.

Read the full story